Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer.
Ilhan Y, Tatli AM, Teker F, Onder AH, Kose F, Geredeli C, Karaagac M, Kaplan MA, Inanc M, Goktas Aydin S, Kargi A, Arak H, Ozturk B, Besen AA, Selvi O, Korkmaz M, Oruc Z, Bozkurt O, Bilici A, Bayram S, Dae SA, Ozdogan M, Coskun HS, Sezgin Goksu S. Ilhan Y, et al. Among authors: bilici a. Int J Gynecol Cancer. 2022 Apr 4;32(4):502-507. doi: 10.1136/ijgc-2021-003165. Int J Gynecol Cancer. 2022. PMID: 35086927
The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck.
Uygun K, Bilici A, Karagol H, Caloglu M, Cicin I, Aksu G, Fayda M, Uzunoglu S. Uygun K, et al. Among authors: bilici a. Cancer Chemother Pharmacol. 2009 Aug;64(3):601-5. doi: 10.1007/s00280-008-0911-7. Epub 2009 Jan 3. Cancer Chemother Pharmacol. 2009. PMID: 19123002 Clinical Trial.
Malignancies diagnosed during pregnancy and treated with chemotherapy or other modalities (review of 27 cases): multicenter experiences.
Anatolian Medical Oncology Society Group; Ustaalioglu BB, Gumus M, Unal A, Cayir K, Sever O, Bilici A, Elkiran ET, Karaca H, Benekli M, Karaoglu A, Seker M. Anatolian Medical Oncology Society Group, et al. Among authors: bilici a. Int J Gynecol Cancer. 2010 Jul;20(5):698-703. doi: 10.1111/igc.0b013e3181daaf3e. Int J Gynecol Cancer. 2010. PMID: 20973261 Review.
Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.
Bilici A, Inanc M, Ulas A, Akman T, Seker M, Babacan NA, Inal A, Bal O, Koral L, Sevinc A, Tufan G, Elkiran ET, Ustaalioglu BB, Yavuzsen T, Alkis N, Ozkan M, Gumus M. Bilici A, et al. Asian Pac J Cancer Prev. 2014 Jan;14(11):6493-9. doi: 10.7314/apjcp.2013.14.11.6493. Asian Pac J Cancer Prev. 2014. PMID: 24377556 Free article.
Medication errors in chemotherapy preparation and administration: a survey conducted among oncology nurses in Turkey.
Ulas A, Silay K, Akinci S, Dede DS, Akinci MB, Sendur MA, Cubukcu E, Coskun HS, Degirmenci M, Utkan G, Ozdemir N, Isikdogan A, Buyukcelik A, Inanc M, Bilici A, Odabasi H, Cihan S, Avci N, Yalcin B. Ulas A, et al. Among authors: bilici a. Asian Pac J Cancer Prev. 2015;16(5):1699-705. doi: 10.7314/apjcp.2015.16.5.1699. Asian Pac J Cancer Prev. 2015. PMID: 25773812 Free article.
240 results